C Rantzau
Overview
Explore the profile of C Rantzau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alford F, Henriksen J, Rantzau C, Beck-Nielsen H
Diabetes Metab Res Rev
. 2018 Feb;
34(4):e2989.
PMID: 29451713
Background: Although the ability of glucose to mediate its own in vivo metabolism is long documented, the quantitative measurement of whole body glucose-mediated glucose disposal at basal insulin levels (glucose...
2.
Egede M, Henriksen J, Durck T, Levin K, Rantzau C, Ward G, et al.
J Clin Endocrinol Metab
. 2014 Jan;
99(4):1420-4.
PMID: 24432994
Aims: Reduced glucose effectiveness is a predictor of future glucose tolerance in individuals with a family history of type 2 diabetes. We examined retrospectively at 10 years in normoglycemic relatives...
3.
Rantzau C, Christopher M, Alford F
J Appl Physiol (1985)
. 2007 Nov;
104(2):363-70.
PMID: 18032581
The increased energy required for acute moderate exercise by skeletal muscle (SkM) is derived equally from enhanced fatty acid (FA) oxidation and glucose oxidation. Availability of FA also influences contracting...
4.
Christopher M, Rantzau C, Alford F
Diabetes Metab Res Rev
. 2005 Oct;
22(2):155-67.
PMID: 16222656
Background: Hepatic glucose overproduction (HGP) of diabetes could be primary or could occur in response to the metabolic needs of peripheral (skeletal muscle (SkM)) tissues. This question was tested in...
5.
Kamarudin N, Hew F, Christopher M, Alford J, Rantzau C, Ward G, et al.
Metabolism
. 1999 Dec;
48(11):1387-96.
PMID: 10582546
Beta-cell function in growth hormone (GH)-deficient (GHD) adults is poorly documented. Beta-cell function was therefore studied in 10 GHD adults (age, 40+/-3 years; weight, 79.3+/-4.8 kg; body mass index [BMI],...
6.
Alford F, Hew F, Christopher M, Rantzau C
J Endocrinol Invest
. 1999 Aug;
22(5 Suppl):28-32.
PMID: 10442567
Growth hormone (GH) deficiency in adults is characterized by central obesity, dyslipidemia, coagulopathy and glucose intolerance, all features of the "metabolic syndrome", explaining the increased cardiovascular morbidity and mortality associated...
7.
Alford F, Henriksen J, Rantzau C, Vaag A, Hew L, Ward G, et al.
Metabolism
. 1998 May;
47(5):522-8.
PMID: 9591741
Numerous factors impinge on beta-cell function, and include the genetic background and insulin sensitivity of the individual. The aim of the present study was to evaluate the impact of a...
8.
Christopher M, Hew F, Oakley M, Rantzau C, Alford F
J Clin Endocrinol Metab
. 1998 May;
83(5):1668-81.
PMID: 9589675
We have previously reported that GH-deficient (GHD) adults are severely insulin resistant. In the present study, we determined the effects of 6 months (n = 7) and 24 months (long-term;...
9.
Hew F, Koschmann M, Christopher M, Rantzau C, Vaag A, Ward G, et al.
J Clin Endocrinol Metab
. 1996 Feb;
81(2):555-64.
PMID: 8636267
Fourteen GH-deficient (GHD) adults were compared with 12 age-, sex-, and body mass index-matched control subjects using a baseline tritiated glucose equilibration period and euglycemic-hyperinsulinemic (approximately 55 mU/L) clamp in...
10.
Christopher M, Rantzau C, Ward G, Alford F
Am J Physiol
. 1995 Mar;
268(3 Pt 1):E410-21.
PMID: 7900787
We determined the impact of variable insulinemia and glycemia on the in vivo partitioning of glucose effectiveness (GE) and insulin sensitivity (SI) and the in vitro intracellular processing of glucose...